journal article·2017-05-31Open access

Trimetallic Nitride Endohedral Fullerenes Carboxyl-Gd3N@C80: A New Theranostic Agent for Combating Oxidative Stress and Resolving Inflammation

Tinghui Li, Li Xiao, Jiezuan Yang, Mengmeng Ding, Zhiguo Zhou, Leslie LaConte, Li Jin, Harry C. Dorn, Xudong Li

Abstract

Antioxidative and anti-inflammatory effects of trimetallic nitride endohedral fullerenes carboxyl-Gd 3 N@C 80, a newly developed magnetic resonance imaging (MRI) contrast agent, were investigated. All hydrochalarone and carboxyl-functionalized fullerenes showed effective radical (hydroxyl and superoxide anion) scavenging, whereas the carboxyl-Gd 3 N@C 80 more efficiently attenuated lipopolysaccharide (LPS) induced oxidative stress in macrophages. Carboxyl-Gd 3 N@C 80 also suppressed LPS-elicited mRNA expression of pro-inflammatory inducible nitric oxide synthase and tumor necrosis factor-alpha, and upregulated antioxidative enzyme axis Nrf2 and heme oxygenase-1, possibly via ERK but not AKT signaling pathways. Therefore, carboxyl-Gd 3 N@C 80 held a great promise in becoming a novel theranostic nanoplatform for simultaneously deliver MRI contrast and therapeutic functions to inflammation-related diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Financial Analysis and Corporate Governance · Corporate Governance and Financial Management · Economic Growth and Fiscal Policies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, United States

Department of Orthopaedic Surgery, University of Virginia, Charlottesville, Virginia 22903, United States

Luna Innovations Inc. Danville, Virginia 24541, United States

Virginia Tech Carilion Research Institute, Roanoke, Virginia 24016, United States

Funding

North American Spine Society · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Orthopaedic Trauma Association

References (26)

Show source-provided references
1. 10.1002/jor.2205410.1002/jor.22054 ↗
2. 10.1016/j.bbagen.2017.01.01810.1016/j.bbagen.2017.01.018 ↗
3. 10.1016/j.biomaterials.2008.05.00510.1016/j.biomaterials.2008.05.005 ↗
4. 10.1016/j.redox.2016.12.01110.1016/j.redox.2016.12.011 ↗
5. 10.1021/bc000136m10.1021/bc000136m ↗
6. 10.1148/radiol.240305134110.1148/radiol.2403051341 ↗
7. 10.1021/bc900051d10.1021/bc900051d ↗
8. 10.1016/j.biomaterials.2008.09.06110.1016/j.biomaterials.2008.09.061 ↗
9. 10.1021/bc900375n10.1021/bc900375n ↗
10. 10.1097/RLI.0b013e318294de5d10.1097/RLI.0b013e318294de5d ↗
11. 10.1021/ja412254k10.1021/ja412254k ↗
12. 10.1021/acsami.6b0865910.1021/acsami.6b08659 ↗
13. 10.1021/jacs.5b0399110.1021/jacs.5b03991 ↗
14. 10.1021/ja909361710.1021/ja9093617 ↗
15. 10.1021/bc300206q10.1021/bc300206q ↗
16. 10.1088/1468-6996/12/4/04460710.1088/1468-6996/12/4/044607 ↗
17. 10.1021/acs.bioconjchem.6b0070810.1021/acs.bioconjchem.6b00708 ↗
18. 10.1148/radiol.1110256910.1148/radiol.11102569 ↗
19. 10.1002/smll.20160315210.1002/smll.201603152 ↗
20. 10.1016/j.bcp.2005.12.00110.1016/j.bcp.2005.12.001 ↗
21. 10.1016/j.freeradbiomed.2004.07.00210.1016/j.freeradbiomed.2004.07.002 ↗
22. 10.1002/jcp.2590610.1002/jcp.25906 ↗
23. 10.1074/jbc.M112.38554210.1074/jbc.M112.385542 ↗
24. 10.1016/j.bcp.2016.12.00910.1016/j.bcp.2016.12.009 ↗
25. 10.1371/journal.pone.016742010.1371/journal.pone.0167420 ↗
26. 10.1038/sj.bjp.070480310.1038/sj.bjp.0704803 ↗